This event is archived. Final snapshot from when the story concluded. View on Dashboard
Domestic medical claims

RFK Jr. Links Tylenol, Circumcision, Autism

Analysis based on 9 articles · First reported Oct 09, 2025 · Last updated Oct 11, 2025

Sentiment
-20
Attention
2
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The unproven claims by Robert F. Kennedy Jr. and Donald Trump linking Tylenol to autism could negatively impact public perception and sales of Tylenol, affecting its manufacturer Kenvue. It also creates uncertainty and concern among pregnant women and parents, potentially leading to a decline in acetaminophen use despite medical expert endorsements.

Pharmaceuticals Healthcare

Health Secretary Robert F. Kennedy Jr. made controversial and unproven claims during a Cabinet meeting with President Donald Trump, asserting a link between infant circumcision, the use of Tylenol, and autism. He claimed circumcised boys given Tylenol have double the rate of autism, referencing a 2015 study that showed correlation but not causation and lacked data on painkiller use. Kennedy also reiterated broader discredited theories connecting Tylenol use during pregnancy to autism and suggested those who dismissed his claims were motivated by hatred for Donald Trump. Donald Trump publicly supported these warnings, urging pregnant women and parents not to use Tylenol. Medical experts, including the Society for Maternal-Fetal Medicine and the American College of Obstetricians and Gynecologists, refuted these claims, endorsing acetaminophen as safe for use during pregnancy. Tylenol's manufacturer, Kenvue, also stated there is no causal link between acetaminophen use during pregnancy and fetal developmental issues. Kennedy's remarks have renewed concerns among medical experts about his promotion of scientifically disputed health beliefs.

per
As the Health Secretary, Robert F. Kennedy Jr. made controversial and unproven claims linking Tylenol and circumcision to autism, drawing criticism from medical experts and potentially undermining public health policy.
Importance 100.0 Sentiment -50.0
per
Donald Trump publicly supported Robert F. Kennedy Jr.'s unproven claims about Tylenol and autism, urging pregnant women and parents not to use the pain reliever, which drew criticism from medical experts.
Importance 80.0 Sentiment -20.0
stock
Kenvue, the manufacturer of Tylenol, refuted the claims made by Robert F. Kennedy Jr. and Donald Trump, stating that studies have found no causal link between acetaminophen use during pregnancy and fetal developmental issues.
Importance 70.0 Sentiment -20.0
ngo
The Society for Maternal-Fetal Medicine endorsed the use of acetaminophen during pregnancy, directly contradicting the claims made by Robert F. Kennedy Jr. and Donald Trump.
Importance 30.0 Sentiment 0.0
ngo
The American College of Obstetricians and Gynecologists endorsed the use of acetaminophen during pregnancy and criticized the claims made by Robert F. Kennedy Jr. and Donald Trump as irresponsible and not backed by scientific evidence.
Importance 30.0 Sentiment 0.0
govactor
The United States — Food and Drug Administration advises against the use of ibuprofen after 20 weeks of pregnancy, making acetaminophen a common alternative for pregnant women, which is relevant to the discussion around Tylenol.
Importance 30.0 Sentiment 0.0
per
U.S. Senator Bill Cassidy emphasized that taking Tylenol remains a safe method to reduce pain and fevers in pregnancy, countering the claims made by Robert F. Kennedy Jr. and Donald Trump.
Importance 10.0 Sentiment 0.0
govactor
The United States — Centers for Disease Control and Prevention previously debunked Robert F. Kennedy Jr.'s claims linking thimerosal in vaccines to autism.
Importance 10.0 Sentiment 0.0
ngo
The World Health Organization previously debunked Robert F. Kennedy Jr.'s claims linking thimerosal in vaccines to autism.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.